Showing results (1701-1710 of 2,365) with videos related to

Sort By:
Pageof 237
Urologia Internationalis|August 4, 2016
Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results DatabaseJonas Schiffmann, Alessandro Larcher, Maxine Sun, et al.
Clinical Genitourinary Cancer|August 28, 2025
The Influence of Lymphovascular Invasion on T Stage Upstaging and Overall Survival in Renal Cell Carcinoma: A Population-Based StudyGiacomo Musso, Giuseppe Garofano, Mai Dabbas, et al.
Clinical Genitourinary Cancer|May 17, 2017
Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database AnalysisEmanuele Zaffuto, Raisa Pompe, Marc Zanaty, et al.
The Prostate|May 4, 2011
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneumAlberto Briganti, Nazareno Suardi, Paolo Capogrosso, et al.
European Urology|October 30, 2007
Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliterSascha A Ahyai, Markus Graefen, Thomas Steuber, et al.
European Urology|April 25, 2017
The Microbiome of the Prostate Tumor MicroenvironmentIlaria Cavarretta, Roberto Ferrarese, Walter Cazzaniga, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2025
Testis Molecular Pathways in CAIS Unveil Testosterone/Estradiol on Germ Cell Tumor Risk in Non-Obstructive AzoospermiaMassimo Alfano, Anna Sofia Tascini, Filippo Pederzoli, et al.
BJU International|June 14, 2026
Paediatric penile length: a systematic review and meta-analysisFausto Negri, Federico Belladelli, Chiyuan A Zhang, et al.
European Urology|March 6, 2012
High-risk prostate cancer: from definition to contemporary managementPatrick J Bastian, Stephen A Boorjian, Alberto Bossi, et al.
European Urology Oncology|August 15, 2019
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade GroupsFelix Preisser, Marco Bandini, Sebastiano Nazzani, et al.
Pageof 237